J
Jon Hill
Researcher at Boehringer Ingelheim
Publications - 10
Citations - 323
Jon Hill is an academic researcher from Boehringer Ingelheim. The author has contributed to research in topics: Kidney disease & Diabetic nephropathy. The author has an hindex of 5, co-authored 10 publications receiving 203 citations.
Papers
More filters
Journal ArticleDOI
Renal compartment–specific genetic variation analyses identify new pathways in chronic kidney disease
Chengxiang Qiu,Shizheng Huang,Jihwan Park,YoSon Park,Yi-An Ko,Matthew J. Seasock,Joshua S. Bryer,Xiang Xi Xu,Wen-Chao Song,Matthew Palmer,Jon Hill,Paolo Guarnieri,Julie Hawkins,Carine M. Boustany-Kari,Steven S. Pullen,Christopher D. Brown,Katalin Susztak +16 more
TL;DR: Kidney compartment–specific eQTL analysis goes beyond GWAS to reveal causal genes and pathways involved in renal disease development, and reduces Dab2 expression in renal tubules protected mice from CKD.
Journal ArticleDOI
Cheminformatic/bioinformatic analysis of large corporate databases: Application to drug repurposing
TL;DR: By reviewing how current and past successes have been accomplished along with the data used, important stratagems emerge that can provide a wealth of ideas for novel workflows, as well as provide a guide for future discoveries.
Journal ArticleDOI
Changes in Albuminuria But Not GFR are Associated with Early Changes in Kidney Structure in Type 2 Diabetes.
Helen C. Looker,Michael Mauer,Pierre Jean Saulnier,Pierre Jean Saulnier,Jennifer L. Harder,Viji Nair,Carine M. Boustany-Kari,Paolo Guarnieri,Jon Hill,Cordell A. Esplin,Matthias Kretzler,Robert G. Nelson,Behzad Najafian +12 more
TL;DR: In American Indians with type 2 diabetes and preserved GFR at baseline, increasing ACR reflects the progression of earlier structural glomerular lesions, whereas early GFR decline may not accurately reflect such lesions.
Journal ArticleDOI
Emerging therapeutics for the treatment of diabetic nephropathy.
TL;DR: This review seeks to provide new insight on emerging clinical candidates under investigation for the treatment of diabetic nephropathy, the largest non-communicable cause of death worldwide.
Journal ArticleDOI
Molecular characterization and cell type composition deconvolution of fibrosis in NAFLD.
Lorena Pantano,George Agyapong,Yang Shen,Zhu Zhuo,Francesc Fernandez-Albert,Werner Rust,Dagmar Knebel,Jon Hill,Carine M. Boustany-Kari,Julia F Doerner,Jörg F. Rippmann,Raymond T. Chung,Shannan J. Ho Sui,Eric Simon,Kathleen E. Corey +14 more
TL;DR: In this paper, the authors investigated the molecular mechanisms of NAFLD and fibrosis using total RNA-Seq and identified gene expression clusters that strongly correlate with fibrosis stage including four genes that have been found consistently across previously published transcriptomic studies on NASH i.e. COL1A2, EFEMP2, FBLN5 and THBS2.